Lion Biotechnologies CEO Maria Fardis' 2018 pay jumps 1,005% to $9.4M

Lion Biotechnologies reports 2018 executive compensation

By ExecPay News

Published: April 29, 2019

Lion Biotechnologies reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, three executives at Lion Biotechnologies received on average a compensation package of $3.5M, a 228% increase compared to previous year.
Average pay of disclosed executives at Lion Biotechnologies
Maria Fardis, Chief Executive Officer, received $9.4M in total, which increased by 1,005% compared to 2017. 88% of Fardis' compensation, or $8.3M, was in option awards. Fardis also received $510K in non-equity incentive plan and $600K in salary.
For fiscal year 2018, the median employee pay was $312,125 at Lion Biotechnologies. Therefore, the ratio of Maria Fardis' pay to the median employee pay was 30 to one.
Timothy E. Morris, Chief Financial Officer, received a compensation package of $603K, which decreased by 60% compared to previous year. 75% of the compensation package, or $450K, was in salary.
Frederick G. Vogt, General Counsel, earned $503K in 2018, a 41% decrease compared to previous year.

Related executives

Maria Fardis

Lion Biotechnologies

Chief Executive Officer

Timothy Morris

Lion Biotechnologies

Chief Financial Officer

Frederick Vogt

Lion Biotechnologies

General Counsel

You may also like

Source: SEC filing on April 29, 2019.